Nureca Ltd
NSE:NURECA

Watchlist Manager
Nureca Ltd Logo
Nureca Ltd
NSE:NURECA
Watchlist
Price: 311.85 INR 5% Market Closed
Market Cap: 3.1B INR

Profitability Summary

Nureca Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Nureca Ltd

Revenue
1.3B INR
Cost of Revenue
-814.9m INR
Gross Profit
486.3m INR
Operating Expenses
-509.1m INR
Operating Income
-22.8m INR
Other Expenses
63.9m INR
Net Income
41.1m INR

Margins Comparison
Nureca Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Nureca Ltd
NSE:NURECA
3.1B INR
37%
-2%
3%
US
Abbott Laboratories
NYSE:ABT
211.7B USD
56%
18%
32%
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.8B USD
66%
29%
29%
US
Stryker Corp
NYSE:SYK
139.1B USD
65%
22%
12%
US
Boston Scientific Corp
NYSE:BSX
130.5B USD
69%
19%
14%
IE
Medtronic PLC
NYSE:MDT
124B USD
66%
19%
14%
DE
Siemens Healthineers AG
XETRA:SHL
51.7B EUR
39%
14%
9%
US
Becton Dickinson and Co
NYSE:BDX
59.1B USD
46%
16%
8%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57.2B USD
62%
31%
25%
US
Edwards Lifesciences Corp
NYSE:EW
49B USD
78%
28%
23%
US
Resmed Inc
NYSE:RMD
37.6B USD
60%
33%
27%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Nureca Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Nureca Ltd
NSE:NURECA
3.1B INR
2%
2%
-1%
-3%
US
Abbott Laboratories
NYSE:ABT
211.7B USD
31%
18%
12%
20%
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.8B USD
17%
15%
17%
22%
US
Stryker Corp
NYSE:SYK
139.1B USD
14%
6%
14%
12%
US
Boston Scientific Corp
NYSE:BSX
130.5B USD
13%
7%
11%
9%
IE
Medtronic PLC
NYSE:MDT
124B USD
10%
5%
8%
7%
DE
Siemens Healthineers AG
XETRA:SHL
51.7B EUR
12%
5%
10%
6%
US
Becton Dickinson and Co
NYSE:BDX
59.1B USD
7%
3%
7%
6%
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57.2B USD
65%
31%
58%
35%
US
Edwards Lifesciences Corp
NYSE:EW
49B USD
14%
10%
14%
16%
US
Resmed Inc
NYSE:RMD
37.6B USD
25%
19%
26%
22%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less